Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 158 articles:
HTML format
Text format



Single Articles


    April 2017
  1. GAY CL, Bosch RJ, Ritz J, Hataye JM, et al
    Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. THUONG NTT, Heemskerk D, Tram TTB, Thao LTP, et al
    Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. VAN LAARHOVEN A, Dian S, Ruesen C, Hayati E, et al
    Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. CHOI JY, Pond SLK, Anderson CM, Richman DD, et al
    Molecular Features of the V1-V4 Coding Region of Sexually Transmitted HIV-1.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. SYPSA V, Psichogiou M, Paraskevis D, Nikolopoulos G, et al
    Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. CHAN PA, Flanigan TP
    Effective HIV Prevention Interventions and the Need for Rapid Mobilization to Address HIV Outbreaks Among At-Risk Populations.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format    


  7. HERRERA BB, Chang CA, Hamel DJ, Mboup S, et al
    Continued transmission of Zika virus in humans in West Africa, 1992-2016.
    J Infect Dis. 2017 Apr 8. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  8. VERMUND SH
    The Continuum of HIV Care in the Urban United States: Black Men Who Have Sex With Men (MSM) Are Less Likely Than White MSM to Receive Antiretroviral Therapy.
    J Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format    


  9. RAHIMY E, Li FY, Hagberg L, Fuchs D, et al
    Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
    J Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. HOOTS BE, Finlayson TJ, Wejnert C, Paz-Bailey G, et al
    Updated Data on Linkage to Human Immunodeficiency Virus Care and Antiretroviral Treatment Among Men Who Have Sex With Men-20 Cities, United States.
    J Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. DING Y, Lin H, Liu X, Wong FY, et al
    Higher Prevalence of Frailty Among a Sample of HIV-Infected Middle-aged and Older Chinese Adults Is Associated With Neurocognitive Impairment and Depressive Symptoms.
    J Infect Dis. 2017 Mar 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. WYLES D, Saag M, Viani RM, Lalezari J, et al
    TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.
    J Infect Dis. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. LEE S, Byakwaga H, Boum Y, Burdo TH, et al
    Immunologic Pathways that Predict Mortality in HIV-Infected Ugandans Initiating ART.
    J Infect Dis. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  14. TER KUILE FO, Taylor SM
    Gilding the lily?: Enhancing antenatal malaria prevention in HIV-infected women.
    J Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format    


  15. NATUREEBA P, Kakuru A, Muhindo M, Littmann E, et al
    Intermittent Preventive Treatment with Dihydroartemisinin-piperaquine for the Prevention of Malaria among HIV-infected Pregnant Women.
    J Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. PHILLIPS AN, Stover J, Cambiano V, Nakagawa F, et al
    Impact of HIV drug resistance on HIV/AIDS associated mortality, new infections and antiretroviral therapy program costs in sub-Saharan Africa.
    J Infect Dis. 2017 Feb 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. LEVIS W
    Clofazimine mechanisms of action in Mycobacteria, HIV, and Cancer.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  18. HANNA DB, Lin J, Post WS, Hodis HN, et al
    Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  19. JANES HE, Cohen KW, Frahm N, De Rosa SC, et al
    Higher T cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  20. FEINSTEIN MJ, Lloyd-Jones DM
    Macrophage inflammation and cardiovascular disease in HIV: Mechanistic Insights and Future Directions.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    


  21. DZANIBE S, Adrian PV, Mlacha SZ, Dangor Z, et al
    Reduced Transplacental Transfer of Group B Streptococcus Surface Protein Antibodies in HIV-infected Mother-Newborn Dyads.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  22. KHOURY G, Fromentin R, Solomon A, Hartogensis W, et al
    HIV persistence and T-cell activation in blood, rectal and lymph node tissue in HIV-infected individuals receiving suppressive ART.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  23. GARGANO JW, Unger ER, Liu G, Steinau M, et al
    Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  24. UPRETY P, Lindsey JC, Levin MJ, Rainwater-Lovett K, et al
    Inflammation and Immune Activation in Antiretroviral-Treated HIV-1-Infected African Infants and Rotavirus Vaccine Responses.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


    January 2017
  25. MARGOT NA, Wong P, Kulkarni R, White K, et al
    Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse Transcriptase and Protease in Antiretroviral Treatment-Naive Patients do not Affect Response to Tenofovir Disoproxil Fumarate- or Tenofovir Alafenamide-Containing Regimens.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. CELUM C, Hong T, Cent A, Donnell D, et al
    HSV-2 acquisition among HIV-1 infected adults treated with tenofovir as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. LOFGREN S, Hullsiek KH, Morawski BM, Nabeta HW, et al
    Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. LIN WW, Nelson A, Ryon JJ, Moss WJ, et al
    Plasma cytokines and chemokines in Zambian children with measles: innate responses and association with HIV-1 co-infection and in-hospital mortality.
    J Infect Dis. 2017 Jan 24. pii: jix012. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. ZANNI MV, Toribio M, Wilks MQ, Lu MT, et al
    Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV.
    J Infect Dis. 2017 Jan 16. doi: 10.1093.
    PubMed     Text format    


  30. JANSSEN S, Schutz C, Ward AM, Huson MA, et al
    Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study.
    J Infect Dis. 2017;215:247-258.
    PubMed     Text format     Abstract available


  31. HOBBS CV, Anderson C, Neal J, Sahu T, et al
    Trimethoprim-Sulfamethoxazole Prophylaxis During Live Malaria Sporozoite Immunization Induces Long-Lived, Homologous, and Heterologous Protective Immunity Against Sporozoite Challenge.
    J Infect Dis. 2017;215:122-130.
    PubMed     Text format     Abstract available


  32. NYOMBAYIRE J, Anzala O, Gazzard B, Karita E, et al
    First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
    J Infect Dis. 2017;215:95-104.
    PubMed     Text format     Abstract available


  33. OTTICHILO RK, Polyak CS, Guyah B, Singa B, et al
    Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
    J Infect Dis. 2017;215:88-94.
    PubMed     Text format     Abstract available


    December 2016
  34. CHENG A, Chang SY, Sun HY, Tsai MS, et al
    Long-term durability of responses to 2 or 3 doses of hepatitis A vaccination in HIV-positive adults on antiretroviral therapy.
    J Infect Dis. 2016 Dec 23. pii: jiw605. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. GRABOWSKI MK, Gravitt PE, Gray RH, Serwadda D, et al
    Trends and determinants of human papillomavirus concordance among HIV-positive and HIV-negative heterosexual couples in Rakai, Uganda.
    J Infect Dis. 2016 Dec 23. pii: jiw631. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. EVANS C, Chasekwa B, Rukobo S, Govha M, et al
    CMV acquisition and inflammation in HIV-exposed uninfected Zimbabwean infants.
    J Infect Dis. 2016 Dec 23. pii: jiw630. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. BIRSE KD, Romas LM, Guthrie BL, Nilsson P, et al
    Genital injury signatures and microbiome alterations associated with depot medroxyprogesterone acetate usage and intravaginal drying practices.
    J Infect Dis. 2016 Dec 23. pii: jiw590. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. BALKUS JE, Srinivasan S, Anzala O, Kimani J, et al
    Impact of periodic presumptive treatment for bacterial vaginosis on the vaginal microbiome among women participating in the Preventing Vaginal Infections trial.
    J Infect Dis. 2016 Dec 22. pii: jiw622. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. MESQUITA PM, Preston-Hurlburt P, Keller MJ, Vudattu N, et al
    Role of IL-32 in HIV Reactivation and its Link to HIV-HSV Coinfection.
    J Infect Dis. 2016 Dec 22. pii: jiw612. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. BIALAS KM, Westreich D, Cisneros de la Rosa E, Nelson CS, et al
    Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants.
    J Infect Dis. 2016;214:1916-1923.
    PubMed     Text format     Abstract available


  41. STEEGEN K, Bronze M, Papathanasopoulos MA, van Zyl G, et al
    Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa.
    J Infect Dis. 2016;214:1826-1830.
    PubMed     Text format     Abstract available


  42. MARAIS S, Lai RP, Wilkinson KA, Meintjes G, et al
    Inflammasome activation underlies central nervous system deterioration in HIV-associated tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  43. MCFARLAND EJ, Powell TM, Onyango-Makumbi C, Zhang W, et al
    Ontogeny of CD4+ T Lymphocytes with Phenotypic Susceptibility to HIV-1 during Exclusive and Non-Exclusive Breastfeeding in HIV-1-exposed Ugandan Infants.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  44. DZANIBE S, Adrian PV, Kimaro Mlacha SZ, Dangor Z, et al
    Reduced trans-placental transfer of group B Streptococcus surface protein antibodies in HIV-infected mother-newborn dyads.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  45. TSO FY, Sawyer A, Kwon EH, Mudenda V, et al
    Kaposi's sarcoma-associated herpesvirus infection of neurons in HIV positive patients.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  46. BRAUNSTEIN SL, Robertson MM, Myers J, Abraham B, et al
    Increase in CD4+ T-Cell Count at the Time of HIV Diagnosis and Antiretroviral Treatment Initiation Among Persons With HIV in New York City.
    J Infect Dis. 2016;214:1682-1686.
    PubMed     Text format     Abstract available


    November 2016
  47. ALTHOFF KN
    The Shifting Paradigm of Care for Adults Living With HIV: Smoking Cessation for Longer Life.
    J Infect Dis. 2016.
    PubMed     Text format    


  48. REDDY KP, Parker RA, Losina E, Baggett TP, et al
    Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  49. GULICK RM, Wilkin TJ, Chen YQ, Landovitz RJ, et al
    PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305).
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  50. GUNTHARD HF, Scherrer AU
    HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance.
    J Infect Dis. 2016;214:1289-1291.
    PubMed     Text format    


    October 2016
  51. ERLANDSON KM, Ng D, Jacobson LP, Margolick JB, et al
    Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men with or at Risk for HIV.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  52. IMP BM, Rubin LH, Tien PC, Plankey MW, et al
    Monocyte Activation is Associated with Worse Cognitive Performance in Virologically Suppressed HIV-Infected Women.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  53. ANDERSON AM, Munoz-Moreno JA, McClernon D, Ellis RJ, et al
    Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  54. MUDD JC, Panigrahi S, Kyi B, Moon SH, et al
    Inflammatory function of CX3CR1+ CD8 T cells in treated HIV infection is modulated by platelet interactions.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  55. ECKARD AR, Meissner EG, Singh I, McComsey GA, et al
    Cardiovascular Disease, Statins, and HIV.
    J Infect Dis. 2016;214 Suppl 2:S83-92.
    PubMed     Text format     Abstract available


  56. KOETHE JR, Heimburger DC, PrayGod G, Filteau S, et al
    From Wasting to Obesity: The Contribution of Nutritional Status to Immune Activation in HIV Infection.
    J Infect Dis. 2016;214 Suppl 2:S75-82.
    PubMed     Text format     Abstract available


  57. GIANELLA S, Letendre S
    Cytomegalovirus and HIV: A Dangerous Pas de Deux.
    J Infect Dis. 2016;214 Suppl 2:S67-74.
    PubMed     Text format     Abstract available


  58. MUDD JC, Brenchley JM
    Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.
    J Infect Dis. 2016;214 Suppl 2:S58-66.
    PubMed     Text format     Abstract available


  59. FREEMAN ML, Shive CL, Nguyen TP, Younes SA, et al
    Cytokines and T-Cell Homeostasis in HIV Infection.
    J Infect Dis. 2016;214 Suppl 2:S51-7.
    PubMed     Text format     Abstract available


  60. HUNT PW, Lee SA, Siedner MJ
    Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.
    J Infect Dis. 2016;214 Suppl 2:S44-50.
    PubMed     Text format     Abstract available


  61. SIEG SF
    Persistent Inflammation in Treated HIV Disease.
    J Infect Dis. 2016;214 Suppl 2:S43.
    PubMed     Text format    


    September 2016
  62. KOOIJ KW, Wit FW, Booiman T, van der Valk M, et al
    Cigarette smoking and inflammation, monocyte activation and coagulation in HIV-infected individuals on antiretroviral therapy compared to uninfected individuals.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  63. EDEN A, Nilsson S, Hagberg L, Fuchs D, et al
    Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: a Longitudinal Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  64. WANG L, Wiener J, Bulterys M, Wei X, et al
    Hepatitis B Viral Load Response to two Antiviral Regimens (Tenofovir/Lamivudine vs Lamivudine) in HIV and HBV Co-Infected Pregnant Women in Guangxi, China: the Tenofovir in Pregnancy (TiP) Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  65. BUCHACZ K, Lau B, Jing Y, Bosch R, et al
    Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.
    J Infect Dis. 2016;214:862-72.
    PubMed     Text format     Abstract available


  66. FURRER H
    Opportunistic Diseases During HIV Infection-Things Aren't What They Used to Be, or Are They?
    J Infect Dis. 2016;214:830-1.
    PubMed     Text format    


  67. PETERSON I, Bar-Zeev N, Kennedy N, Ho A, et al
    Respiratory virus-associated severe acute respiratory illness (SARI) and viral clustering in Malawian children in a setting with a high prevalence of HIV, malaria and malnutrition.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  68. POPESCU I, Drummond MB, Gama L, Lambert A, et al
    HIV Suppression Restores Lung Mucosal CD4+ T-Cell Viral Immunity and Resolves CD8+ Alveolitis in Patients at Risk for HIV-associated COPD.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  69. IMAZ A, Martinez-Picado J, Niubo J, Kashuba AD, et al
    HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Initiating a First Antiretroviral Regimen.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  70. COOMBS RW, Krieger JN
    Semen Remains the Way Forward to understand HIV-1 Transmission.
    J Infect Dis. 2016.
    PubMed     Text format    


  71. RODRIGO C, Eltahla AA, Bull RA, Grebely J, et al
    Historical trends in the hepatitis C virus epidemics in North America and Australia.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  72. GUTIERREZ J, Menshawy K, Goldman J, Dwork AJ, et al
    Metalloproteinases and brain arterial remodeling with and without HIV.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  73. SRINIVASA S, Burdo TH, Williams KC, Mitten EK, et al
    Effects of Sodium Restriction on Activation of the Renin-Angiotensin-Aldosterone System and Immune Indices in HIV.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  74. KOSTADINOVA L, Shive C, Judge C, Zebrowski E, et al
    During HCV and HCV-HIV infection elevated plasma Autotaxin is associated with LPA and markers of immune activation that normalize during IFN-free HCV therapy.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  75. MOFENSON LM
    Early Infant HIV Diagnosis: How Early is Early Enough?
    J Infect Dis. 2016.
    PubMed     Text format    


  76. FRANCKE JA, Penazzato M, Hou T, Abrams EJ, et al
    Clinical impact and cost-effectiveness of early infant HIV diagnosis in South Africa: Test timing and frequency.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  77. WALTER ND, de Jong BC, Garcia BJ, Dolganov GM, et al
    Adaptation of M. tuberculosis to impaired host immunity in HIV-infected patients.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  78. REIMERS LL, Mehta SD, Massad LS, Burk RD, et al
    The Cervicovaginal Microbiota and Its Associations with Human Papillomavirus (HPV) Detection in HIV-Infected and HIV-Uninfected Women.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  79. MARKOWITZ M, Deren S, Cleland C, La Mar M, et al
    Chronic hepatitis C infection and the pro-inflammatory effects of injection drug use.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  80. KILIANSKI A, Nuzzo JB, Modjarrad K
    Reply to Lipsitch.
    J Infect Dis. 2016.
    PubMed     Text format    


  81. GONZALEZ OA, Sagar M
    Antibodies and acidic environment do not enhance HIV-1 transcytosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  82. RYOM L, Lundgren JD, Ross M, Kirk O, et al
    Renal Impairment and Cardiovascular Disease in HIV-positive Individuals; The D:A:D Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  83. FIERER DS
    The Order of Addition of Immunocompromise: The Effects of HIV Infection on Fibrosis Progression of Hepatitis C-infected Patients.
    J Infect Dis. 2016.
    PubMed     Text format    


    July 2016
  84. MASSUD I, Mitchell J, Babusis D, Deyounks F, et al
    Chemoprophylaxis with oral emtricitabine and tenofovir alafenamide combination protects macaques from rectal SHIV infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  85. WALL KM, Kilembe W, Vwalika B, Ravindhran P, et al
    Hormonal contraceptive use among HIV-positive women and HIV transmission risk to male partners, Zambia, 1994-2012.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  86. DIEDRICH CR, O'Hern J, Gutierrez MG, Allie N, et al
    Relationship between HIV-1 co-infection, IL-10, and M. tuberculosis in human lymph node granulomas.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  87. CANADAY DH, Toossi Z
    Granulomatous responses in HIV/TB co-infection.
    J Infect Dis. 2016.
    PubMed     Text format    


  88. BAETEN JM
    Making an Impact With Preexposure Prophylaxis for Prevention of HIV Infection.
    J Infect Dis. 2016.
    PubMed     Text format    


  89. JENNESS SM, Goodreau SM, Rosenberg E, Beylerian EN, et al
    Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  90. BOENDER TS, Hamers RL, Ondoa P, Wellington M, et al
    Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  91. DERUAZ M, Moldt B, Le KM, Power KA, et al
    Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  92. HUNT PW
    sCD163 and Clinical Outcomes in Treated HIV: Insights into Mechanisms.
    J Infect Dis. 2016.
    PubMed     Text format    


  93. KELESIDIS T, Moser C, Stein JH, Brown TT, et al
    Changes in markers of T cell senescence and exhaustion with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  94. KNUDSEN TB, Ertner G, Petersen J, Moller HJ, et al
    Plasma CD163 independently predicts all-cause mortality from HIV-1 infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  95. GRANT PM, Kitch D, McComsey GA, Collier AC, et al
    Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  96. MEITES E, Gorbach PM, Gratzer B, Panicker G, et al
    Monitoring for HPV Vaccine Impact among Gay, Bisexual and other Men who have Sex with Men - United States, 2012-2014.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  97. CHEN YI MEI SL, Burchell J, Skinner N, Millen R, et al
    Toll-like receptor expression and signalling in peripheral blood mononuclear cells correlate with clinical outcomes in acute hepatitis C infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  98. LAPRISE JF, Markowitz LE, Chesson HW, Drolet M, et al
    COMPARING 2- AND 3-DOSE 9-VALENT HPV VACCINE SCHEDULES IN THE U.S.: A COST-EFFECTIVENESS ANALYSIS.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  99. WHITE E, Smit E, Churchill D, Collins S, et al
    No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  100. SHILAIH M, Marzel A, Scherrer AU, Braun DL, et al
    Dually Active HIV/HBV Antiretrovirals Protect Against Incident Hepatitis B Infections: Potential for Prophylaxis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  101. PRENDERGAST AJ, Szubert AJ, Berejena C, Pimundu G, et al
    Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016
  102. BEDNAR MM, Hauser BM, Zhou S, Jacobson JM, et al
    Diversity and Tropism of HIV-1 Plasma Rebound Virus after Treatment Discontinuation.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  103. BORGES AH, O'Connor JL, Phillips AN, Neaton JD, et al
    IL-6 is a stronger predictor of clinical events than hsCRP or D-dimer during HIV infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  104. SCHERRER AU, Yang WL, Kouyos RD, Boni J, et al
    Successful prevention of transmission of integrase resistance in the Swiss HIV Cohort Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  105. BUCKNER CM, Kardava L, Zhang X, Gittens K, et al
    Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burden.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  106. KIMANI D, Kamau R, Gadde R, Selenic D, et al
    Findings of Phlebotomy Practices in Kenya in 2010: Need for Action.
    J Infect Dis. 2016;213 Suppl 2:S53-8.
    PubMed     Text format     Abstract available


  107. SKAGGS B, Pinto I, Masamha J, Turgeon D, et al
    Implementing Laboratory Quality Management Systems in Mozambique: The Becton Dickinson-US President's Emergency Plan for AIDS Relief Public-Private Partnership Initiative.
    J Infect Dis. 2016;213 Suppl 2:S47-52.
    PubMed     Text format     Abstract available


  108. SHRIVASTAVA R, Gadde R, Nkengasong JN
    Importance of Public-Private Partnerships: Strengthening Laboratory Medicine Systems and Clinical Practice in Africa.
    J Infect Dis. 2016;213 Suppl 2:S35-40.
    PubMed     Text format     Abstract available


  109. HADER SL
    Role of Public-Private Partnerships in Meeting Healthcare Challenges in Africa: A Perspective From the Public Sector.
    J Infect Dis. 2016;213 Suppl 2:S34.
    PubMed     Text format    


  110. COBOS JIMENEZ V, Wit FW, Joerink M, Maurer I, et al
    T-cell activation independently associates with immune senescence in long-term antiretroviral drug-treated HIV-1-infected individuals.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  111. SIMONS BC, Spradling PR, Bruden DJ, Zanis C, et al
    A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B cellular immunity despite loss of antibody against hepatitis B surface antigen.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  112. MURPHY K, Mitchell CM
    The interplay of host immunity and environment on risk for bacterial vaginosis and associated reproductive health outcomes.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  113. MUJUGIRA A, Coombs RW, Heffron R, Celum C, et al
    Seminal HIV-1 RNA Detection in Heterosexual African Men Initiating Antiretroviral Therapy.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  114. PHILLIPS A, Cambiano V, Revill P, Nakagawa F, et al
    Identifying key drivers of the impact of an HIV cure intervention in sub-Saharan Africa.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  115. MUGWANYA K, Baeten J, Celum C, Donnell D, et al
    Low risk of Proximal Tubular Dysfunction Associated with Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis in Men and Women.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  116. JOSEPH DAVEY DL, Beymer MR, Roberts C, Bolan RK, et al
    Sexual behavior during acute HIV infection among men who have sex with men in Los Angeles, California.
    J Infect Dis. 2016.
    PubMed     Text format    


  117. MOQUEET N, Cooper C, Gill J, Hull M, et al
    Responder Interferon Lambda genotypes are associated with higher risk of liver fibrosis in HIV-Hepatitis C Virus Co-infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  118. MAVE V, Erlandson KM, Gupte N, Balgopal A, et al
    Inflammation and Change in Body Weight with Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-infected Adults.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  119. LEITMAN EM, Hurst J, Mori M, Kublin J, et al
    Lower Viral Loads and Slower CD4 Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  120. GALLAGHER KE, Baisley K, Grosskurth H, Vallely A, et al
    The association between cervical human papillomavirus infection and subsequent HIV acquisition in Tanzanian and Ugandan women: a nested case-control study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  121. OKEKE NL, Hicks CB, McKellar MS, Fowler VG Jr, et al
    History of Aids in HIV-infected Patients is Associated with Higher in-hospital Mortality Following Admission for Acute Myocardial Infarction and Stroke.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    February 2016
  122. GANTT S, Orem J, Krantz EM, Morrow RA, et al
    Prospective characterization of the risk factors for transmission and symptoms of primary human herpesvirus infections among Ugandan infants.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  123. COTTRELL ML, Yang KH, Prince HM, Sykes C, et al
    A Translational Pharmacology Approach to Predicting HIV Pre-Exposure Prophylaxis Outcomes in Men and Women Using Tenofovir Disoproxil Fumarate+/-Emtricitabine.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  124. O'CONNELL RJ, Excler JL, Polonis VR, Ratto-Kim S, et al
    Safety and Immunogenicity of a randomized Phase I prime-boost trial with ALVAC-HIV (vCP205) and Oligomeric gp160 MN/LAI-2 Adjuvanted in Alum or Polyphosphazene.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  125. KATRAK S, Day N, Ssemmondo E, Kwarisiima D, et al
    Community-wide prevalence of malaria parasitemia in HIV-infected and uninfected populations in a high transmission setting in Uganda.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  126. CHESSON HW, Laprise JF, Brisson M, Markowitz LE, et al
    The Impact and Cost-Effectiveness of 3 doses of 9-Valent Human Papillomavirus (HPV) Vaccine among US Females Previously Vaccinated with 4-Valent HPV Vaccine.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  127. MEYS R, Purdie KJ, de Koning MN, Quint KD, et al
    HLA immunogenotype determines persistent HPV infection in anti-retroviral treated HIV.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  128. BALKUS JE, Manhart LE, Lee J, Anzala O, et al
    Periodic presumptive treatment for vaginal infections may reduce the incidence of bacterial sexually transmitted infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    January 2016
  129. ZAMAN K, Fleming JA, Victor JC, Yunus M, et al
    Non-interference of rotavirus vaccine with measles-rubella vaccine at 9 months and improvements in anti-rotavirus immunity: a randomized trial.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  130. KLING HM, Norris KA
    Vaccine-induced Immunogenicity and Protection against Pneumocystis pneumonia in Non-human Primate Model of HIV-Pneumocystis Co-Infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  131. BRUCE MG, Bruden D, Hurlburt D, Zanis C, et al
    Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  132. DEHON PM, Hagensee ME, Sutton KJ, Oddo HE, et al
    Histological Evidence of Chronic Mycoplasma genitalium-Induced Cervicitis in HIV-Infected Women: A Retrospective Cohort Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  133. PIROTH L, Launay O, Michel ML, Bourredjem A, et al
    Vaccination against hepatitis B virus in HIV-1 infected patients with isolated anti-HBc: the ANRS HB EP03 CISOVAC prospective study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  134. FROST SD, Kwofie SK
    Surveys, serology and sequences reveal history of iatrogenic transmission of HIV-1.
    J Infect Dis. 2016.
    PubMed     Text format    


  135. HOGAN C, Iles J, Frost EH, Giroux G, et al
    Epidemic history and iatrogenic transmission of blood-borne viruses in mid-20th century Kinshasa.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  136. PATEL EU, Cox AL, Mehta SH, Boon D, et al
    Hepatitis C IgG antibody avidity as a biomarker to estimate population-level incidence.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  137. SCRIVEN JE, Graham LM, Schutz C, Scriba TJ, et al
    A glucuronoxylomannan-associated immune signature, characterized by monocyte deactivation and raised IL-10, is a predictor of death in cryptococcal meningitis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  138. RADZIO J, Henning T, Jenkins L, Ellis S, et al
    Combination emtricitabine and tenofovir disoproxil fumarate prevents vaginal SHIV infection in macaques harboring C. trachomatis and T. vaginalis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  139. PAPP E, Balogun K, Banko N, Mohammadi H, et al
    Low prolactin and high 20alpha-hydroxysteroid dehydrogenase contribute to lower progesterone in HIV-infected protease inhibitor-cART exposed pregnant women.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    December 2015
  140. RAGONNET-CRONIN M, Lycett S, Hodcroft E, Hue S, et al
    Transmission of non-B HIV subtypes in the UK is increasingly driven by large non-heterosexual clusters.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  141. FIFE KH, Mugwanya K, Thomas KK, Baeten JM, et al
    Transient Increase in HSV-2-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV-1/HSV-2 Co-Infected Individuals.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  142. HEARD I, Poizot-Martin I, Potard V, Etienney I, et al
    Prevalence of and risk factors for Anal Oncogenic human papillomavirus infection among HIV-Infected Women in France in the cART era.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  143. KALLIANPUR AR, Wang Q, Jia P, Hulgan T, et al
    Anemia and Red Cell Indices Predict HIV-Associated Neurocognitive Impairment in the HAART Era.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  144. LANDOVITZ RJ, Grinsztejn B
    Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention in South Africa: Is There a Will and a Way?
    J Infect Dis. 2015.
    PubMed     Text format    


  145. WALENSKY RP, Jacobsen MM, Bekker LG, Parker RA, et al
    Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  146. PANIGRAHI S, Freeman ML, Funderburg NT, Mudd JC, et al
    SIV/SHIV Infection Triggers Vascular Inflammation, Diminished Expression of Kruppel-like factor 2 (KLF2) and Endothelial Dysfunction.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  147. MATTHEWS PC, Carlson JM, Beloukas A, Malik A, et al
    HLA-A is a Predictor of Hepatitis B e-Antigen Status in HIV-positive African Adults.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  148. MARRA CM, Tantalo LC, Sahi SK, Dunaway SB, et al
    Treponema pallidum-specific Opsonic Antibody Activity is Reduced in HIV-Infected Patients with Syphilis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  149. MACATANGAY BJ, Riddler SA, Wheeler ND, Spindler J, et al
    Therapeutic vaccination with dendritic cells loaded with autologous HIV-1-infected apoptotic cells.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    November 2015
  150. SWANSON S, Ma Y, Scherzer R, Huhn G, et al
    Association of HIV, HCV and Liver Fibrosis Severity with the Enhanced Liver Fibrosis Score.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  151. SHIVAKOTI R, Yang WT, Berendes S, Mwelase N, et al
    Persistently elevated CRP in first year of ART despite virologic suppression is associated with HIV disease progression in resource constrained settings.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  152. BOILLAT-BLANCO N, Ramaiya KL, Mganga M, Minja LT, et al
    Transient Hyperglycemia in Patients with Tuberculosis in Tanzania: Implications for Diabetes Screening Algorithms.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  153. GRABOWSKI MK, Kong X, Gray RH, Serwadda D, et al
    Partner human papillomavirus viral load and incident human papillomavirus detection in heterosexual couples.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  154. ELLINGTON SR, Clarke KE, Kourtis AP
    Cytomegalovirus Infection in the Human Immunodeficiency Virus-Exposed and Infected Infant: A Systematic Review.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  155. PENROSE K, Parikh UM, Hamanishi KA, Else L, et al
    Selection of Rilpivirine Resistant HIV-1 in a Seroconverter on Long-Acting Rilpivirine (TMC278LA) from the Lowest Dose Arm of the SSAT040 Trial.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  156. MORON-LOPEZ S, Gomez-Mora E, Salgado M, Ouchi D, et al
    Short-term treatment with IFNalpha diminishes expression of HIV-1 and reduces CD4+ T-cell activation in HIV/HCV-coinfected patients on antiretroviral therapy.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    October 2015
  157. RICHARDSON BA, John-Stewart G, Atkinson C, Nduati R, et al
    Vertical cytomegalovirus transmission from HIV-infected women randomized to formula feeding versus breastfeeding.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  158. DE PABLO-BERNAL RS, Ramos R, Genebat M, Canizares J, et al
    Phenotype and polyfunctional deregulation involving IL-6- and IL-10-producing monocytes of HIV-infected patients on cART differ from those of aging.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: